James P. Crowley and Professor Erwin Loh About Caffeine and It’s Positive Effects
James P. Crowley, Professor of Medicine emeritus at Brown University, reposted Professor Erwin Loh’s post on LinkedIn:
“Caffeine appears to do the opposite of what you might think when it comes to the heart. Scientists have found that a cup of coffee a day actually protects the heart from atrial fibrillation – a condition that can lead to stroke and heart failure.
In the DECAF (Does Eliminating Coffee Avoid Fibrillation) trial, the researchers found that caffeine resulted in a 39% lower risk of recurrent AF events, compared to those who abstained – and they have a few theories as to why this might be the case.
“Coffee increases physical activity which is known to reduce AF,” said senior author Professor Gregory Marcus from the Division of Cardiology at UCSF.
“Caffeine is also a diuretic which could potentially reduce blood pressure and in turn lessen AF risk.
Several other ingredients in coffee also have anti-inflammatory properties that could have positive effects.””
Quoting Professor Erwin Loh’s post:
“Caffeine appears to do the opposite of what you might think when it comes to the heart. Scientists have found that a cup of coffee a day actually protects the heart from atrial fibrillation – a condition that can lead to stroke and heart failure.
In the DECAF (Does Eliminating Coffee Avoid Fibrillation) trial, the researchers found that caffeine resulted in a 39% lower risk of recurrent AF events, compared to those who abstained – and they have a few theories as to why this might be the case.
“Coffee increases physical activity which is known to reduce AF,” said senior author Professor Gregory Marcus from the Division of Cardiology at UCSF. “Caffeine is also a diuretic which could potentially reduce blood pressure and in turn lessen AF risk. Several other ingredients in coffee also have anti-inflammatory properties that could have positive effects.”
Title: Caffeinated Coffee Consumption or Abstinence to Reduce Atrial Fibrillation
Authors: Christopher X. Wong, Christopher C. Cheung, Gabrielle Montenegro, Hannah H. Oo, Isabella J. Peña, Janet J. Tang, Samuel J. Tu, Grace Wall, Thomas A. Dewland, Joshua D. Moss, Edward P. Gerstenfeld, Zian H. Tseng, Henry H. Hsia, Randall J. Lee, Jeffrey E. Olgin, Vasanth Vedantham, Melvin M. Scheinman, Catherine Lee, Prashanthan Sanders, Gregory M. Marcus
Read full article here.
Stay updated with Hemostasis Today.
-
May 31, 2026, 16:29José Antonio García Erce: Collaborative PBM Implementation in Transfusion Centers and Services
-
May 31, 2026, 16:22Vera Ignjatović: How Do We Rigorously Study These Drugs in Children to Understand Their True Benefits and Risks?
-
May 31, 2026, 16:21Ksenija Stach: Is This The Future of Lipid-Lowering Lherapy?
-
May 31, 2026, 15:42Antonio Greco: Balancing Bleeding and Thrombotic Risk After PCI
-
May 31, 2026, 15:41Eric Topol: Replication of Plasma p-tau217 Blood Test for Predicting Alzheimer’s Disease
-
May 31, 2026, 15:32ASH Invites Dynamic Members to Apply for 2027 Leadership and Committee Roles
-
May 31, 2026, 14:39Monique Gore-Massy: Redefining Lupus Innovation Through Patient Partnership
-
May 31, 2026, 14:31Mirjam Teboe: The Golden Rule Behind Reliable Lupus Anticoagulant Testing
-
May 31, 2026, 14:20Improving Access to Care for People Living with Haemophilia and Haemoglobinopathies – NNHF